Clinical trials and clinical practice - bridging the gaps in type 2 diabetes - An evidence-based approach to risk factor modification in type 2 diabetes

被引：4
|
作者：
Greenfield, JR
Chisholm, DJ
机构：
[1] St Vincents Hosp, Dept Endocrinol, Sydney, NSW, Australia
[2] Garvan Inst Med Res, Sydney, NSW, Australia
[3] Univ New S Wales, Sydney, NSW, Australia
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 2000年 / 30卷 / 04期
关键词：
D O I：
10.1111/j.1445-5994.2000.tb02056.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：483 / 491
页数：9
相关论文
共 50 条
  • [21] Early introduction of insulin glargine in type 2 diabetes in everyday practice and in clinical trials
    Janka, HU
    Plewe, G
    Schneider, K
    Kliebe-Frisch, C
    Schweitzer, MA
    DIABETES, 2005, 54 : A143 - A143
  • [22] Use of type 2 diabetes risk scores in clinical practice: a call for action
    Nowak, Christoph
    Ingelsson, Erik
    Fall, Tove
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (03): : 166 - 167
  • [23] Pharmacologic Randomized Clinical Trials in Prevention of Type 2 Diabetes
    Knowler, William C.
    Crandall, Jill P.
    CURRENT DIABETES REPORTS, 2019, 19 (12)
  • [24] Pharmacologic Randomized Clinical Trials in Prevention of Type 2 Diabetes
    William C. Knowler
    Jill P. Crandall
    Current Diabetes Reports, 2019, 19
  • [25] SAFETY OF DAPAGLIFLOZIN IN CLINICAL TRIALS FOR TYPE 2 DIABETES MELLITUS
    Ptaszynska, Agata
    Johnsson, Kristina
    Apanovitch, Anne Marie
    Sugg, Jennifer
    Parikh, Shamik
    List, James
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 50 - 50
  • [26] Challenging Recruitment of Youth With Type 2 Diabetes Into Clinical Trials
    Nguyen, Tammy T.
    Jayadeva, Vikas
    Cizza, Giovanni
    Brown, Rebecca J.
    Nandagopal, Radha
    Rodriguez, Luisa M.
    Rother, Kristina I.
    JOURNAL OF ADOLESCENT HEALTH, 2014, 54 (03) : 247 - 254
  • [27] Drugs in Phase 3 Clinical Trials for Type 2 Diabetes
    Goodman, Alice
    AMERICAN HEALTH AND DRUG BENEFITS, 2011, 4 (06): : 410 - 410
  • [28] Therapy and clinical trials: type 2 diabetes: lifestyle and beyond
    Owen, P
    Evans, M
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (03) : 351 - 353
  • [29] Safety of dapagliflozin in clinical trials for type 2 diabetes mellitus
    Johnsson, K.
    Ptaszynska, A.
    Apanovitch, A.
    Sugg, J. E.
    Parikh, S. J.
    List, J. F.
    DIABETOLOGIA, 2012, 55 : S304 - S304
  • [30] An Evidence-Based and Practical Approach to Using Bydureon™ in Patients With Type 2 Diabetes
    Painter, Nathan A.
    Morello, Candis M.
    Singh, Renu F.
    McBane, Sarah E.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2013, 26 (02) : 203 - 210
12345